Healthier lifestyles 'could cut cancer death rates'
Conclusion
This prospective cohort study assessed the number of cancer cases and related deaths associated with poor lifestyle factors in a sample of US health professionals.
As the findings demonstrate, a large number of cancer cases and deaths in both men and women can be attributed to a high-risk lifestyle, such as being overweight, smoking, drinking heavily, or being physically inactive.
Worryingly, a poor lifestyle was estimated to account for an even greater number of cancers in the general population.
These findings are in agreement with much research, which has found that a healthier lifestyle may reduce the risk...
Source: NHS News Feed - May 20, 2016 Category: Consumer Health News Tags: Cancer Lifestyle/exercise Source Type: news
Sclerosing Adenosis Mimicking Malignant Lesion on Breast MRISclerosing Adenosis Mimicking Malignant Lesion on Breast MRI
Sclerosing adenosis is a known mimic of malignancy, and can be extremely difficult to distinguish radiologically from breast carcinoma, requiring biopsy for final diagnosis. Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2016 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
What Is Invasive Ductal Carcinoma (IDC)?
What kind of breast cancer is invasive ductal carcinoma (IDC)? What are the symptoms, characteristics, treatments and prognosis? (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - April 24, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016
Contact: Samiha KhannaPhone: 919-419-5069Email: samiha.khanna@duke.eduhttps://www.dukehealth.org
FOR IMMEDIATE RELEASE on Thursday, April 21, 2016
DURHAM, N.C. -- Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute, has been named one of TIME’s 100 most influential people for 2016 as a pioneer in her field.
One of the world’s foremost experts in early-stage breast cancers, Hwang has become an international leader calling for research to guide treatment for ductal carcinoma in situ (DCIS), in which abnormal cells are detected in the lining of a milk duct, but haven’t spread to other tissues.
DCIS...
Source: DukeHealth.org: Duke Health Features - April 22, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news
Delayed rad therapy puts women with DCIS at risk
Women being treated for ductal carcinoma in situ (DCIS) are at higher risk...Read more on AuntMinnie.comRelated Reading:
Socioeconomic factors affect patient care in radiology
Racial discrepancies persist in breast cancer diagnoses
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients
ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2016 Category: Radiology Source Type: news
Early stage breast cancer does need treatment, study finds
Kathleen Doheny, HealthDay News Early stage breast cancers known as DCIS, ductal carcinoma in situ, should be treated with surgery, not a "wait-and-watch" approach, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 15, 2016 Category: Consumer Health News Source Type: news
Early Stage Breast Cancer Does Need Treatment, Study Finds
FRIDAY, April 15, 2016 -- Early stage breast cancers known as DCIS (ductal carcinoma in situ) should be treated with surgery, not a "wait-and-watch" approach, according to new research.
Experts have debated whether to treat early DCIS or simply... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2016 Category: Journals (General) Source Type: news
ASBrS: No, we're not overtreating DCIS
More than 50% of women diagnosed with ductal carcinoma in situ (DCIS) that...Read more on AuntMinnie.comRelated Reading:
5 ways imaging can reduce breast cancer overdiagnosis
Could a pill improve breast cancer diagnosis?
New study to tackle personalized breast screening
Mammo false-positive rate highest in younger women
Rates of high-grade DCIS increase with age (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 15, 2016 Category: Radiology Source Type: news
ACR and SBI Continue to Recommend Regular Mammography Starting at Age 40
Washington, DC (Oct. 20, 2015) — As our shared goal is to save the most lives possible from breast cancer, the American College of Radiology (ACR) and Society of Breast Imaging (SBI) continue to recommend that women get yearly mammograms starting at age 40. New American Cancer Society (ACS) breast cancer screening guidelines, and previous data used by the United States Preventive Services Task Force (USPSTF) to create their recommendations, state that starting annual mammography at age 40 saves the most lives.
“The ACS has strongly reaffirmed that mammography screening saves lives. The new ACS guidelines show ...
Source: American College of Radiology - April 13, 2016 Category: Radiology Source Type: news
Immune Microenvironment of Breast Ductal Carcinoma In SituImmune Microenvironment of Breast Ductal Carcinoma In Situ
This study investigates the immunobiology of DCIS breast cancers. How does the antitumor immune response evolve as tumors progress from in situ to invasive and then metastatic lesions? Modern Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Dilon, GE present breast biopsy tool at SBI
Dilon Diagnostics and GE Healthcare will present a breast biopsy localization...Read more on AuntMinnie.comRelated Reading:
GE places digital SPECT/CT system in Israel
GE joins Santa Clara Univ. on African initiative
GE eyes Cuba in wake of historic opening
Dilon signs distribution deal with GE
Dilon touts MBI for invasive lobular carcinoma
Dilon: Patient wins legal appeal for MBI coverage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2016 Category: Radiology Source Type: news
Tandem duplicate phenotype detected in triple-negative breast, other cancers
(Jackson Laboratory) A genomic configuration described as a tandem duplicator phenotype is significantly enriched in triple-negative breast cancer, serous ovarian cancer and endometrial carcinomas, and responds to cisplatin chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 4, 2016 Category: Cancer & Oncology Source Type: news
Invasive Lobular Carcinoma -- A Distinct Breast Cancer SubtypeInvasive Lobular Carcinoma -- A Distinct Breast Cancer Subtype
Genomic studies have highlighted invasive lobular cancer as a distinct subset of breast cancer, which may lead to new treatment approaches in the future. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Pathologists Often Disagree on Biopsy FindingsPathologists Often Disagree on Biopsy Findings
Pathologists largely agree when identifying invasive breast cancer on breast biopsy slides, but agreement is much lower when those slides suggest atypia or ductal carcinoma in situ, a new study has found. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 30, 2016 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Janice Dickinson reveals she has been diagnosed with breast cancer
The supermodel tells Daily Mail Online how she has been diagnosed with early stage ductal carcinoma in situ. But Dickinson, 61, said she is determined to beat the disease and will soon have surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2016 Category: Consumer Health News Source Type: news
